Skip to main content
. 2014 Oct 30;8(10):e3172. doi: 10.1371/journal.pntd.0003172

Figure 2. Baseline prevalence of infection, number of subjects eligible for follow-up, losses to follow-up and 18-month cumulative incidence of infection by type of intervention.

Figure 2